−0.40HKD
−697.54 MHKD
805.36 MHKD
851.24 M
About INNOCARE PHARMA LTD
Sector
CEO
Jisong Cui
Headquarters
Beijing
Website
Employees (FY)
1.09 K
Founded
2015
ISIN
KYG4783B1032
FIGI
BBG00S9VV4P0
InnoCare Pharma Ltd. is a clinical-stage biopharmaceutical company. It engages in discovering, developing and commercializing drugs for the treatment of cancer and autoimmune diseases. The company was founded by Jisong Cui and Yigong Shi on November 3, 2015 and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 9969 is 4.55 HKD — it has decreased by 3.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange INNOCARE PHARMA LTD stocks are traded under the ticker 9969.
INNOCARE PHARMA LTD is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for INNOCARE PHARMA LTD has a max estimate of 12.98 HKD and a min estimate of 6.27 HKD.
9969 earnings for the last quarter are −0.31 HKD whereas the estimation was −0.10 HKD which accounts for −211.11% surprise. Estimated earnings for the next quarter are −0.22 HKD. See more details about INNOCARE PHARMA LTD earnings.
INNOCARE PHARMA LTD revenue for the last quarter amounts to 1.16 B HKD despite the estimated figure of 1.12 B HKD. In the next quarter revenue is expected to reach 175.20 M HKD.
Yes, you can track INNOCARE PHARMA LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 9969 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOCARE PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 1.09 K employees. See our rating of the largest employees — is INNOCARE PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOCARE PHARMA LTD EBITDA is −670.97 M HKD, and current EBITDA margin is −83.53%. See more stats in INNOCARE PHARMA LTD financial statements.